|
The Latest on COVID-19
|
|
Updated on January 29, 2021 at 3:00 p.m. PDT |
- Johnson & Johnson announced that its single-dose vaccine provided strong protection against moderate to severe COVID-19. Preliminary results show that the vaccine had an overall effectiveness of 66 percent against moderate to severe infection 28 days after vaccination.
- Severe cases of COVID-19 might influence the quality of sperm, possibly reducing fertility, according to a new study published on Thursday, Jan. 28, in the journal Reproduction.
- The European Union (E.U.) has approved the AstraZeneca COVID-19 vaccine. The E.U. will halt the transportation of any of this vaccine outside of E.U. borders until AstraZeneca has met its supplier obligations, according to the New York Times.
|
Experts say that even with COVID-19 vaccines being distributed, it’s still too early to gather safely in small groups.
|
|
|
|